[Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology / Q000627:therapeutic use*; D004328:Drive / Q000187:drug effects; D004644:Emotions / Q000187:drug effects; D005116:Extrapyramidal Tracts; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D013268:Stimulation, Chemical; D014149:Tranquilizing Agents / Q000009:adverse effects*
D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine
Zur Wirkung von Dioxyphenylalanin (L-DOPA) auf extrapyramidalmotorische Hyperkinesen nach langfristiger neuroleptischer Therapie.